Patient Care Research Group

Patient Care Research Group

Dr Anne Lanceley

Research Group Lead

IRIS Profile

Widget Placeholderhttps://www.youtube.com/watch?v=hCa7tst88og

 

 

Our overall aim is to develop novel strategies for improved health outcomes in psychological response and in the prevention and palliation of disease and treatment related symptoms in women’s cancer. 

Overview

This initiative began in 2008 to help integrate psychosocial research into the work of the Department of Women’s Cancer.

Close collaboration between Anne and her Consultant Clinical Psychologist colleague Dr. Sue Gessler has established a programme of work with a team of doctoral and post doctoral research fellows.

We conduct research that is women centred, clinically applied and relevant to the diversity of women’s lives across the life span.

Patient care research investigates the experiences of individuals in health and illness, with emphasis on health related quality of life and the role of care -givers – self, family, and professionals – in health promotion, psychological response and disease management.

We are committed to develop a research programme which challenges routinised accounts of women’s health and tests new ways of working with women.

The purpose of this is on the one hand, to equip women to more actively manage their own health and meet the challenges posed by their cancer, and on the other, to contribute to an understanding of how health professionals can work to support this, while offering first class clinical care.

Nutrition

Nutritional status and nutritional interventions in Ovarian Cancer

Describing the nutritional status of women newly diagnosed with ovarian cancer and develop effective nutritional interventions. Our work in this area takes account of the complex relation of nutrition with gastrointestinal symptomology in ovarian cancer.

Symptoms

Symptoms in Women's Cancer

Symptom benefit study

Investigating quality of life issues related to ovarian cancer and chemotherapy. We are interested in finding out how women do during chemotherapy and whether symptom improvement occurs with treatment. We will also develop better ways to predict which women may be most likely to benefit from chemotherapy.

Gastrointestinal symptoms in Ovarian Cancer

Optimising women’s self-management of gastro intestinal symptoms in ovarian cancer, we will first identify and provide detailed description of gastrointestinal symptoms and symptom clusters. Then we will refine assessment protocols, and treatment algorithms for improved prevention and relief of the symptoms.

Psychosexual

Innovative  psychological therapies, evaluation and implementation in the clinical setting

SAFFRON- Developing a Stepped Approach to improving Sexual Function aFteR GynaecOlogical CaNcer.  A pilot feasibility trial to assess a stepped model of care for delivering psychosexual support to address sexual difficulties experienced by women post-treatment for gynaecological cancer.

Peer support.

Understanding the psychological mechanisms in peer support between new and post treatment gynaecological cancer patients

Virtual heritage-object therapy.

Developing and testing virtual heritage-object applications for management of cancer related stress.

PROMISE 2016 - Risk stratification, early detection and diagnosis of ovarian cancer.

Evaluating the health behavioural aspects for ovarian cancer risk prediction and screening on a population wide basis.

Interventions to relieve distress and promote psychological wellbeing in advanced cancer.

Assessing the feasibility of training nurse specialists to deliver to a high standard a manualised therapy previously carried out only by psychologically trained personnel. This intervention widens and deepens the traditional role of the nurse specialist, drawing on attachment based therapies with close supervision to allow patients to work on areas where their relationships are changing in the face of advanced disease, and where distress and depression may interfere with the task of facing  a shortened life with comfort, dignity and a sense of meaning.
 

Psychosexual interventions after treatment for gynaecological cancer. Developing and evaluating in a feasibility trial an integrated approach to psychosexual difficulties after treatment.

Publications

Dr Anne Lanceley: Patient Care Research Group Lead

2015

Koutoukidis DA, Knobf T, Lanceley A. (2015) Obesity, Diet, Physical Activity and Health-Related Quality of Life in Endometrial Cancer Survivors: A Systematic Review, Nutrition Reviews. 73(6): 399-408.

Meisel SF, Pashayan N, Rahman B, Side L, Fraser L, Gessler S, Lanceley A, Wardle J. (2015) Adjusting the frequency of mammography screening on the basis of genetic risk: Attitudes among women in the UK. The Breast. 24(3): 237-41.

Rahman  B,  Meisel SF, Fraser L, Side L,  Gessler S, Wardle J, Lanceley A. (2015) Population-based genetic risk prediction and stratification for ovarian cancer: views from women at high risk. Familial Cancer. 14(1): 135-144.

2014

Raine R, Wallace I, Nic a’ Bháird C, Xanthopoulou P, Lanceley A, Clarke A, Prentice A, Ardron D, Harris M, Gibbs JSR, Ferlie E, King M, Blazeby JM, Michie S, Livingston G, Barber J. (2014)  Improving the effectiveness of multidisciplinary team meetings for patients with chronic diseases: a prospective observational study. Health Serv Deliv Res 2 (37).

O'Driscoll W,  Livingston G,  Lanceley A,  Nic a' Bháird, C, Xanthopoulou P,  Wallace I, Manoharan M, Raine R.  (2014) Patient experience of MDT care and decision-making. Mental Health Review Journal. 19(4): 265-278.

Gentry-Maharaj A, Karpinskyj C, Glazer C, Burnell M, Ryan A, Fraser L, Lanceley A, Jacobs I, Hunter MS*, Menon U* (*joint). (2014) Use and perceived efficacy of complementary and alternative medicines following discontinuation of hormone therapy: a nested UKCTOCS cohort study. Menopause (Oct 6).

Raine R, Xanthopoulou P, Wallace I, Nic a’ Bháird C, Lanceley A, Clarke A, Livingston G, Prentice A, Ardron D, Harris M, King M, Michie S, Blazeby J M, Austin-Parsons N, Gibbs S, Barber J (2014). Determinants of treatment plan implementation in multidisciplinary team meetings for patients with chronic diseases: a mixed-methods study. BMJ Quality & Safety. doi:10.1136/bmjqs-2014-002818.

Thomson L, Paddon H, Lanceley A, Menon, U, Chatterjee H. (2014) Mixed methods evaluation of wellbeing benefits derived from a heritage-in-health intervention with hospital patients. Arts & Health. 6(1): 24-58.

2013

Lanceley A, Fiander A, McCormack M, Bryant A. Follow-up protocols for women with cervical cancer after primary treatment. Cochrane Database of Systematic Reviews 2013, Issue 11. Art. No.: CD008767. DOI: 10.1002/14651858.CD008767.pub2.

Meisel SF, Side L,  Fraser L,  Gessler S,  Wardle J,  Lanceley A. (2013)  Population-Based, Risk-Stratified Genetic Testing for Ovarian Cancer Risk: A Focus Group Study. Public Health Genomics. 16: 184-191.

Stark D, Nankivell M, Pujade-Lauraine E, Kristensen G, Elit L, Stockler M, Hilpert F, Cervantes A, Brown J, Lanceley A, Velikova G, Sabate E, Pfisterer J, Carey MS, Beale P, Qian W, Swart AM, Oza A, Perren T. (2013) Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial. Lancet Oncology. 14(3): 236-243.

Weis J, Arraras JI, Conroy T, Efficace F, Fleissner C, Görög A, Hammerlid E, Holzner B, Jones L, Lanceley A, Singer S, Wirtz M, Flechtner H, Bottomley A. (2013) Development of an EORTC quality of life phase III module measuring cancer-related fatigue (EORTC QLQ-FA13). Psychooncology. 22(5): 1002-7. doi: 10.1002/pon.3092.

Ander EE,  Thomson LJ, Menon U,  Lanceley A,  Chatterjee HJ. (2013) Using museum objects to improve wellbeing in psychiatric and rehabilitation patients. British Journal of Occupational Therapy. 76(5): 208-216.

Lanceley, A. Macleod Clarke, J. (2013) Cancer in other words? The role of metaphor in emotion disclosure in cancer patients. British Journal of Psychotherapy. 29(2): 182-20.

Lanceley A. (2013) The clinical nurse specialists case load: contending with the fretful elements IN The topic of cancer: new perspectives on the emotional experience of cancer.  Jonathan Burke (Ed) Karnac.  London. pp 93-107.

2012

Hunter MS, Gentry-Maharaj A, Ryan A, Burnell M, Lanceley A, Fraser L, Jacobs I, Menon U. (2012) Prevalence, frequency and problem rating of hot flushes persist in older postmenopausal women: impact of age, body mass index, hysterectomy, hormone therapy use, lifestyle and mood in a cross-sectional cohort study of 10,418 British women aged 54-65. British Journal of Obstetrics and Gynaecology. 119(1): 40-50.

Thomson LJ,  Ander EE, Menon U,  Lanceley A,  Chatterjee HJ. (2012) Enhancing Cancer Patient Well-Being with a Nonpharmacological, Heritage-Focused Intervention. Journal of Pain and Symptom Management. 44(5): 731-740.

Ander E, Thomson l, Noble G, Lanceley A, Menon U, Chatterjee H. (2012) Heritage, health and well-being: assessing the impact of a heritage focused intervention on health and well-being. International Journal of Heritage Studies. DOI:10.1080/13527258.2011.651740.

Balogun N, Forbes A, Widschwendter M, Lanceley A. (2012) Noninvasive nutritional management of ovarian cancer patients: beyond intestinal obstruction. International Journal of  Gynecological Cancer. 22(6): 1089-95.

Lanceley A, Eagle Z, Ogden G, Gessler S, Razvi K, Ledermann J, Side L. (2012) Family history and women with ovarian cancer: Is it asked and does it matter? International Journal of Gynaecological Cancer. 22(2): 254-259.

Thomson LJM, Ander EE, Menon U, Lanceley A, Chatterjee HJ.  (2012) Quantitative evidence for wellbeing benefits from a heritage-in-health intervention with hospital patients. International Journal of Art Therapy. 17(20): 63-79.

Lanceley, A. Noble, G. Johnson, M. Balogun, N. Chatterjee, H. Menon, U.  (2012) Investigating the therapeutic potential of a heritage-object focused intervention. Journal of Health Psychology.  17(6): 809-820.

2011

Thomson LJ, Ander EE, Menon U, Lanceley A, Chatterjee HJ (2011) Evaluating the therapeutic effects of museum object handling with hospital patients: A review and initial trial of wellbeing measures. Journal of Applied Arts and Health. 2(1): 37-56.

Ander, E., Thomson, L., Lanceley, A., Menon, U., Noble, G. and Chatterjee, H.J. (2011) Generic Wellbeing Outcomes: Towards a conceptual framework for wellbeing outcomes in museums. Journal of Museum Management and Curatorship. 26(3): 237-259.

Lanceley, A. (2011) Ovarian cancer: Symptoms, treatment and long term patient management. Cancer Nursing Practice. 10(4): 29-36.

Greimel E, Nordin A, Lanceley A, Creutzberg CL, van de Poll-Franse LV, Radisic VB, Galalae R, Schmalz C, Barlow E, Jensen PT, Waldenström AC, Bergmark K, Chie WC, Kuljanic K, Costantini A, Singer S, Koensgen D, Menon U, Daghofer F; on behalf of the EORTC Quality of Life Group. (2011) Psychometric validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Endometrial Cancer Module (EORTC QLQ-EN24). European Journal of Cancer. 47(2): 183-90.

2010

Lanceley A, McCormack M, Armstrong E, Fiander A, Jefferies H, Barrett M, Brown J, Burton S, Leach M, Morton P, Smith LA. Follow up protocols for women with cervical cancer after primary treatment (Protocol). Cochrane Database of Systematic Reviews 2010, Issue 10. Art. No.: CD008767. DOI: 10.1002/14651858.CD008767.

2008

Lanceley, A. Savage, J. Menon, U Jacobs, I (2008) Influences on multidisciplinary team decision-making. International Journal of Gynaecological Cancer. 18(2): 215-222.

Lanceley, A (2008) The impact of cancer on health care professionals. In Corner, J.C. and Bailey, C. (eds.) Cancer nursing: care in context. 2nd Edition. Blackwell, Oxford pp153-171.

Lanceley, A. (2008) Therapeutic strategies in cancer care. In Corner, J.C. and Bailey, C. (eds) Cancer nursing: care in context. 2nd Edition. Blackwell, Oxford. pp172 – 192.

2007

Weis J, Gao Y, Conroy T, Singer S, Hammerlid E, Holzner B, Fleissner C, Efficace F, Arraras J, Bottomley A, Flechtner H, Lanceley A, Jones L (2007). Development of an EORTC module for the assessment of cancer related fatigue (EORTC FAR-15): Phase III results. 2007 International Society for Quality of Life Research meeting abstracts [www.isoQol.org/2007mtgabstracts.pdf]. Quality of Life Research Supplement, A-108, 221: 1624.

Lanceley, A. Cox, C. (2007) Cancer information and support needs of statutory and voluntary sector staff working with people from ethnically diverse communities. The European Journal of Cancer Care. 16(2): 122-9.

2006

Abbott, S. Meyer, J. Bentley, J. Lanceley, A. (2006) Patient Advice and Liaison Services: strengthening the voices of individual service users in health care organisations. Health Expectations. 9: 1-10.

2005

J. Bentley Abbott, S. Meyer, J. Lanceley, A (2005) Horizontal or vertical support: dilemmas for patient advice and liaison services in the NHS Public Policy and Administration. 20(2): 54-66.

Abbott, S. Meyer, J. Copperman, J. Bentley, J. Lanceley, A. (2005) Quality criteria for Patient Advice and Liaison Services: what do patients and the public want? Health Expectations. 8(2): 126-137

Buchanan, D. Abbott, S. Bentley, J. Lanceley, A. Meyer, J. (2005) Let’s be PALS: user-driven organizational change in healthcare. British Journal of Management. 16: 315-328.

Lanceley, A. (2005) New NHS, new networks = new agenda for promoting education for collaboration in cancer and palliative care IN Carlisle, C. Donovan, T. Mercer, D. (Eds) Interprofessional education: An agenda for healthcare professionals . Mark Allen Publishing Ltd. London pp 67-77.

2003

Abbott, S. Bentley, J. Lanceley, A. Meyer, J. (2003) Can GP’s and PALS be friends? The British Journal of General Practice. 818-819.

Abbott, S. Bentley, J. Lanceley, A. Meyer, J. (2003) The early lives and times of PALS. British Journal of Health Care Management. 9(1): 18-20.

2001

Lanceley, A. (2001) Increasing the effectiveness of intervention through multi-disciplinary models of care: the nature of nurse-led intervention. Chapter 11 IN UK Key Advances in effective management of cancer pain, Aesulapius Medical Press, London, pp141-15.

1995

Lanceley, A. (1995) Emotional disclosure in talk between nurses and cancer patients In Wilson-Barnett, J. and Richardson, A. (eds.) Research in cancer nursing Scutari Press, London.

Lanceley, A. (1995) Wider issues in pain management. The European Journal of Cancer Care. 4(4): 153-157.

1985

Lanceley, E.A. (1985) Use of controlling language in the rehabilitation of the elderly. Journal of Advanced Nursing. 10: 125-135.

Patient Care Research Group Team Publications

2015

Koutoukidis DA, Knobf T, Lanceley A. Obesity, Diet, Physical Activity and Health-Related Quality of Life in Endometrial Cancer Survivors: A Systematic Review. Nutrition Reviews. 73(6): 399-408. 

Rahman B, Meisel SF, Fraser L, Side L, Gessler S, Wardle A, Lanceley A. (2015) Population-based genetic risk prediction and stratification for ovarian cancer: views from women at high risk. Familial Cancer. 14: 135-44.

Meisel S, Pashayan N, Rahman B, Side L, Fraser L, Gessler S, Lanceley A, Wardle J. (2015) Adjusting the frequency of mammography screening on the basis of genetic risk: Attitudes among women in the UK. The Breast. 24: 237-241.

Douma KFL, Meiser B, Kirk J, Mitchell G, Saunders C, Rahman B, Sousa MS, Barlow-Stewart K, Gleeson M, Tucker K. (2015) Health professionals’ evaluation of delivering treatment-focused genetic testing to women newly diagnosed with breast cancer. Familial Cancer. 14: 265-72.

Meiser B, Storey B, Quinn V, Rahman B, Andrews L. Acceptability of, and Information Needs Regarding, Next-Generation Sequencing in People Tested for Hereditary Cancer: a Qualitative Study. Journal of Genetic Counselling. Accepted July 2015.

Manchanda R, Legood R, Burnell M, McGuire A, Raikou M, Loggenberg K,  Wardle J, et al. (2015) Cost-effectiveness of population screening for BRCA mutations in Ashkenazi Jewish women compared with family history–based testing. Journal of the National Cancer Institute. 107, no. 1 (2015): dju380.

Manchanda R, Loggenberg K, Sanderson S, Burnell M, Wardle J, Gessler S, Side L. et al. Population testing for cancer predisposing BRCA1/BRCA2 mutations in the Ashkenazi-Jewish community: a randomized controlled trial. Journal of the National Cancer Institute. 107, no. 1 (2015): dju379.

Meisel, SF, Pashayan N, Rahman B, Side L, Fraser L, Gessler S, Lanceley A, and Wardle J. (2015) Adjusting the frequency of mammography screening on the basis of genetic risk: Attitudes among women in the UK. The Breast. 24(3): 237-241.

2014

Moschonis G, Kalliora AC, Costarelli V, Papandreou C, Koutoukidis D, Lionis C, Chrousos GP, Manios Y. (2014) Identification of lifestyle patterns associated with obesity and fat mass levels in children. The Healthy Growth Study. Public Health Nutr. 17(3): 614-24

Manchanda R, Loggenberg K, Sanderson S, Burnell M, Wardle J, Gessler S, Side L, Balogun N, Desai R, Kumar A, Dorkins H, Wallis Y, Chapman C, R, Jacobs C, Tomlinson I, McGuire A, Beller U, Menon U, and Jacobs I. Population testing for cancer predisposing BRCA1/BRCA2 mutations in the Ashkenazi-Jewish community: a randomised controlled trial. JNCI. (2014 In Press).

Sinnerbrink IB, Meiser B, Halliday J, Sherwen A, Amor DJ, Waters E, Rea F, Evans E, Rahman B, Kirk EP. (2014) Prenatally detected de novo apparently balanced chromosomal rearrangements: the effect on maternal worry, family functioning and intent of disclosure. Prenatal Diagnosis. 34(6): 598-604. doi: 10.1002/pd.4363.

Meiser B, Price MA, Butow PN, Rahman B, Tucker K, Cheah B, Bickerstaffe A, Hopper J, Phillips KA. (2014) Misperceptions of ovarian cancer risk in women at increased risk for hereditary ovarian cancer. Familial Cancer. 13(2): 153-62. doi: 10.1007/s10689-013-9687-y.

Fraser L, Burnell M, Salter LC, Fourkala EO, Kalsi J, Ryan A, Gessler S, Gidron Y, Steptoe A, Menon U. (2014) Identifying hopelessness in population research: a validation study of two brief measures of hopelessness. BMJ Open. 30;4(5): e005093. doi: 10.1136/bmjopen-2014-005093.

Manchanda R, Legood R, Burnell M, McGuire A, Raikou M, Loggenberg K, Wardle J, Sanderson S, Gessler S, Side L, Balogun N, Desai R, Kumar A, Dorkins H, Wallis Y, Chapman C, Taylor R, Jacobs C, Tomlinson IP, Beller U, Menon U and Jacobs I. Population-screening for BRCA mutations in Ashkenazi-Jewish women is cost-effective compared to family-history based testing. Journal of the National Cancer Institute. (Provisionally Accepted July 2014).

Michailidou C, Marston L, De Souza LH, Sutherland I. (2014) A systematic review of the prevalence of musculoskeletal pain, back and low back pain in people with spinal cord injury. Disability Rehabilitation. 36(9):705-15. doi: 10.3109/09638288.2013.808708. Epub 2013 Jul 10.

Shaw, C, Gessler, S, and Lanceley, A. (2014) Conversation Practices of Patient and Therapist During First Session Managing Cancer and Living Meaningfully (CALM) Therapy. Psycho-oncology. 23: 27-27.

Meisel S, Rahman B, Gessler S, Side L, Fraser L, Lanceley A, and Wardle J. (2014) Attitudes Towards Screening for Ovarian Cancer Based on Prior Genetic Risk Stratification Among Women in the UK. Psycho-oncology. 23: 307-307.

2013

Meisel SF, Side L, Fraser L, Gessler S,  Wardle J,  Lanceley A. (2013) Population-Based, Risk-Stratified Genetic Testing for Ovarian Cancer Risk: A Focus Group Study. Public Health Genomics. 16: 184-191.

Sinnerbrink IB, Sherwen A, Meiser B, Halliday J, Amor DJ, Waters E, Rea F, Evans E, Rahman B, Kirk EP. (2013) Long-term health and development of children diagnosed prenatally with a de novo apparently balanced chromosomal rearrangement. Prenatal Diagnosis. 33(9): 831-8. doi: 10.1002/pd.4131.

Pistrang N, Jay Z, Gessler S, Barker C. (2013) Telephone peer support for women with gynaecological cancer: benefits and challenges for supporters. Psychooncology. 22(4): 886-94. doi: 10.1002/pon.3080.

Burcher S, Meiser B, Mitchell G, Saunders C, Rahman B, Tucker T, Barlow-Stewart K, Watts K, Gleeson M & Kirk J. (2013) Oncology health professionals’ attitudes towards treatment-focused genetic testing for women newly diagnosed with breast cancer. Personalized Medicine. 10: 431-440 (invited article).

Williams, AC, Morris, J, Stevens, K, Gessler, S, Cella, M, Baxter, J (2013) What influences midwives in estimating labour pain? Eur J Pain. 17(1): 86 - 93.

2012

Lim AW, Mesher D, Gentry-Maharaj A, Balogun N, Jacobs I, Menon U, Sasieni P. (2012) Predictive value of symptoms for ovarian cancer: comparison of symptoms reported by questionnaire, interview, and general practitioner notes. Journal of the National Cancer Institute. 18: 104 (2):114-24. doi: 10.1093/jnci/djr486.

Balogun N, Forbes A, Widschwendter M, Lanceley A. (2012) Noninvasive nutritional management of ovarian cancer patients: beyond intestinal obstruction. International Journal of Gynecological Cancer. 22(6): 1089-95.

Lanceley A, Eagle Z, Ogden G, Gessler S, Razvi K, Ledermann J, Side L. (2012) Family history and women with ovarian cancer: Is it asked and does it matter? International Journal of Gynaecological Cancer. 22(2): 254-259.

Lanceley A, Noble G, Johnson M, Balogun N, Chatterjee H, Menon U.  (2012) Investigating the therapeutic potential of a heritage-object focused intervention. Journal of Health Psychology. 17(6): 809-820.

Watts KJ, Meiser B, Mitchell G, Kirk J, Saunders C, Peate M, Duffy J, Kelly PJ, Gleeson M, Barlow-Stewart K, Rahman B, Friedlander M, Tucker K; TFGT Collaborative Group. (2012) How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer. BMC Cancer. 28(12): 320. doi: 10.1186/1471-2407-12-320.

Rahman B, Macciocca I, Sahhar M, Kamberi S, Connell V. and Duncan RE. (2012) Adolescents with Implantable Cardioverter Defibrillators: A Patient and Parent Perspective. Pacing and Clinical Electrophysiology. 35: 62–72.

Rahman B, Meiser B, Sachdev P, Barlow-Stewart K, Otlowski M, Zilliacus E, Schofield P. (2012) To know or not to know: an update of the literature on the psychological and behavioral impact of genetic testing for Alzheimer disease risk. Genetic Testing and Molecular Biomarkers. 8: 935-42.

Pistrang N, Jay Z, Gessler S, Barker C. (2012) Telephone peer support for women with gynaecological cancer: recipients' perspectives. Psychooncology. 21(10): 1082-90. doi: 10.1002/pon.2005.

Manchanda R, Saridogan E, Abdelraheim A, Johnson M, Rosenthal AN, Benjamin E, Brunell C, Side L, Gessler S, Jacobs I, Menon U. (2012) Annual outpatient hysteroscopy and endometrial sampling (OHES) in HNPCC/Lynch syndrome (LS). Archives of Gynecology and Obstetrics. 286(6): 1555-62. doi: 10.1007/s00404-012-2492-2.

Manchanda R, Loggenberg K, Gessler S, Sanderson S, Balogun N, Wardle J, Tomlinson I, McGuire A, Beller U, Side L, Menon U, Jacobs I. (2012) Population based testing for high-penetrance dominant gene mutations: initial results from the pilot phase of GCaPPS. International Journal of Gynaecological Cancer. 22: S42 - S43.

Manchanda R, Burnell M, Johnson M, Sharma A, Gessler S, Side L, et al (2012) Factors influencing uptake and timing of risk reducing salpingo- oophorectomy in women at risk of familial ovarian cancer: A competing risk time to event analysis. BJOG: An International Journal of Obstetrics and Gynaecology. 119(5): 527 - 536.

2011

Balogun N, Gentry-Maharaj A, Wozniak EL, Lim A, Ryan A, Ramus SJ, Ford J, Burnell M, Widschwendter M, Gessler SF, Gayther SA, Jacobs IJ, Menon U. (2011) Recruitment of newly diagnosed ovarian cancer patients proved challenging in a multicentre biobanking study. Journal of Clinical Epidemiology. 64(5): 525-30.

Johnson M, Gessler S, and Menon U. (2011) The end of the UK Familial Ovarian Cancer Screening Study: high risk patients’ perspectives. The Newsletter of the British Society for Human Genetics. Issue 44 February: 58.

Manchanda R, Abdelraheim A, Johnson M, Rosenthal AN, Benjamin E, Brunell C, Brunell M, Side L, Gessler S, Saridogan E, Oram D, Jacobs I, Menon U.(2011)  Outcome of risk reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status. British Journal of Obstetrics and Gynaecology. 118(7): 814-824.

2009

Low J, Gessler S, Williams R, Daniells E, Brough V, Tookman A, Jones L. (2009) Screening for distress and depression in cancer patients: is ultrashort depression screening a valid measure in the UK? A prospective validation study. Journal of Pain Symptom Management. 38(2): 234-43.

Manchanda R, Menon U, Loggenberg K, Gessler S, Sanderson S, Udeh I, Balogun N, Wardle J, Tomlinson I, McGuire A, Beller U and Jacobs I. (2009) A randomized controlled trial of population testing for BRCA1/2 founder mutations in the Ashkenazi Jewish population. Selected abstracts submitted to the Third International Symposium on Hereditary Breast and Ovarian Cancer, Montreal, October 2009. Curr Oncol. 16(5): 102, 359.

Chapters

Williams, A.C. de C. and Gessler, S. (2010) Empathy and cancer pain. in Cancer Pain: From Molecules to Suffering  eds. Paice, J.A., Bell, R.F., Kalso, E.A. and Soyannwo, O.A.  International Association for the Study of Pain Press: pp 269-284.

Contact Us

Useful links 

• ANZGOG
• OvaCome..
• The Eve Appeal
• The European Academy of Nursing Science
• NFGON
• EORTC Quality of Life
• North London Gynaecological Cancer Centre at UCLH
• Heritage in Hospitals

Study protocols

• Ovarian Follow-up Study

Further information

• Research students